GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [07/30/2026 16:11 PDT] GCTK SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [07/30/2026 16:11 PDT] GlucoTrack, Inc. (NASDAQ:GCTK), Up By 100% ($0.4) From $0.4 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [07/29/2026 16:12 PDT] GlucoTrack, Inc. (NASDAQ:GCTK), Down By 100% ($0.36) From $0.364 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [07/22/2026 07:12 PDT] GCTK Expected to Trade Down After Bearish Patterns Develop
• [07/13/2026 06:30 PDT] GCTK Expected to Trade Up After Bullish Patterns Develop
• [06/29/2026 10:29 PDT] GlucoTrack, Inc. (NASDAQ:GCTK), Down By 100% ($0.42) From $0.42 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [06/12/2026 07:59 PDT] GCTK Expected to Trade Down After Bearish Patterns Develop